Esperion Therapeutics Inc
NASDAQ:ESPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Esperion Therapeutics Inc
NASDAQ:ESPR
|
US |
|
Abb Ltd
OTC:ABLZF
|
CH |
|
P
|
Pfizer Inc
BMV:PFE
|
US |
|
S
|
Silverlake Axis Ltd (Pre Reincorporation)
OTC:SLVFF
|
MY |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
V
|
Vertex Pharmaceuticals Inc
XBER:VX1
|
US |
|
G
|
Graincorp Ltd
XMUN:G3C
|
AU |
|
B
|
Bluebet Holdings Ltd
ASX:BBT
|
AU |
|
W
|
Wells Fargo & Co
SGO:WFC
|
US |
|
B
|
Blue Sky Uranium Corp
F:MAL2
|
CA |
|
BW Offshore Ltd
F:XY81
|
BM |
|
St James's Place PLC
OTC:STJPF
|
UK |
|
Industrivarden AB
F:IDVA
|
SE |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
Establishment Labs Holdings Inc
F:3E0
|
CR |
|
S
|
Sanofi SA
MIL:SANF
|
FR |
|
O
|
Orange SA
MIL:ORA
|
FR |
|
E
|
Eli Lilly and Co
XMUN:LLY
|
US |
|
S
|
Schlumberger NV
SIX:SLB
|
US |
|
C
|
Carrefour SA
XMUN:CAR
|
FR |
|
VRG SA
F:1NL
|
PL |
|
HAL Trust
F:HA4
|
MC |
|
Fagerhult AB
F:2F0
|
SE |
|
U
|
United Parcel Service Inc
XBER:UPAB
|
US |
Bankruptcy Probability
Esperion Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Esperion Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Esperion Therapeutics Inc
NASDAQ:ESPR
|
818.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
613.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
316.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
260.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Esperion Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Esperion Therapeutics Inc has total debt of 460.5m USD. This includes both short-term (0 USD) and long-term (460.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
